Low-molecular-weight heparins in the cardiac catheterization laboratory.
We describe the unique properties of low-molecular-weight heparins and review studies of the use of these agents in the catheterization laboratory for percutaneous coronary intervention. Recent data regarding bedside monitoring of low-molecular-weight heparin activity are also discussed, as are ongoing and future studies that should be of assistance to clinicians as they consider expanding the use of this newer form of anti-thrombotic therapy.
Kadakia
Rajan A
RA
Department of Cardiology Research, Texas Heart Institute, St. Luke's Episcopal Hospital, Houston, Texas 77225-0269, USA.
Baimeedi
Shravantika R
SR
Ferguson
James J
JJ
D015906:Angioplasty, Balloon, Coronary / Q000379:methods*; D000925:Anticoagulants / Q000494:pharmacology / Q000627:therapeutic use*; D006328:Cardiac Catheterization / Q000379:methods*; D006495:Heparin, Low-Molecular-Weight / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007755:Laboratories, Hospital; D016032:Randomized Controlled Trials as Topic
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight